ILMN · XBRL financial data

Illumina financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (ILMN's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 29, 2024Dec 29, 2024Mar 30, 2025Jun 29, 2025Sep 28, 2025Dec 28, 2025Mar 29, 2026Jun 28, 2026Sep 27, 2026
Revenue from contracts with customers1,122*1,0761,1121,0801,104*1,0411,0591,0841,159*1,0911,1591,129
Cost of revenue448*409391335376*358364351400*370389299
Gross profit674*667721745728*683695733759*721770830
Research and development341*339325253256*252247229239*240252244
Selling, general and administrative485*439147239279*267234277309*272273281
Total operating expenses838*7782,3584553*519481506558*512525525
Operating income (loss)(164)*(111)(1,637)741175*164214227201*209245305
Interest income11*12131110*1110910*11812
Interest expense18*18203625*25252526*242424
Other income (expense)4*8(332)427*321079192*(39)31(29)
Income tax expense (benefit)8*1712150*51717043*235344
Net income (loss)(176)(126)(1,988)705186131235150334134207220
Earnings per share, basic USD per share—(0.79)(12.48)4.43—0.831.490.98—0.881.371.46
Earnings per share, diluted USD per share—(0.79)(12.48)4.42—0.821.490.98—0.871.351.43
Weighted average shares, basic millions of shares158*159159159159*159157153151*153151151
Weighted average shares, diluted millions of shares158*159159160158*159157154154*154153154

Balance sheet

CSV

Fiscal quarters (ILMN's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 29, 2024Dec 29, 2024Mar 30, 2025Jun 29, 2025Sep 28, 2025Dec 28, 2025Mar 29, 2026Jun 28, 2026Sep 27, 2026
Cash and cash equivalents1,0481,1089208691,1271,1139341,0501,4181,0891,0401,289
Short-term investments6—7470931242212282156612848
Accounts receivable734635641699735699701729854738764738
Inventory587584561574547537575590564611629667
Prepaid and other current assets234256263161244200210199238234273293
Total current assets2,6092,5832,4592,3732,7462,6732,6412,7963,2892,7382,8343,035
Property and equipment, net1,007964859832815782764748759755745731
Right-of-use asset544550460453419410397382370371362356
Goodwill2,5452,5451,0791,1131,1131,1131,1131,1131,1131,2841,2841,284
Total assets10,11110,0406,0816,0146,3036,1826,0876,1776,6446,5596,6506,812
Accounts payable245201199191221207200218240218230241
Accrued liabilities1,3251,2731,265784827734762746846849848915
Total current liabilities1,5701,4742,2089751,5471,4401,4611,9621,5851,5661,5781,156
Lease liability, non-current687700616613554539528506486475454439
Retained earnings (accumulated deficit)(19)(145)(2,133)(1,428)(1,242)(1,111)(876)(726)(392)(258)(51)169
Total stockholders' equity5,7455,7341,4362,1252,3732,3682,2582,3812,7232,6762,8383,145
Total liabilities and equity10,11110,0406,0816,0146,3036,1826,0876,1776,6446,5596,6506,812
Common shares outstanding (cover page) millions of shares159159159159158158154153153151151151

Cash flows

CSV

Fiscal quarters (ILMN's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 29, 2024Dec 29, 2024Mar 30, 2025Jun 29, 2025Sep 28, 2025Dec 28, 2025Mar 29, 2026Jun 28, 2026Sep 27, 2026
Net income (loss)(176)(126)(1,988)705186131235150334134207220
Stock-based compensation94*96112*83*79*7369*70*63*6073*74*
Depreciation and amortizationyear only1081057071*69686766*———
Net cash from operating activities224*7780*316*364*240234*284*321*289201*419*
Purchases of property and equipment51*3631*32*29*3230*31*55*3840*40*
Net cash from investing activities(85)*(48)(41)*(41)*(48)*(63)(49)*(51)*108*(366)(122)*50*
Proceeds from issuing common stock0*360*20*0*271*16*0*240*22*
Share repurchases0*00*99*17*200370*130*42*242128*9*
Proceeds from long-term debtyear only———0*———495*———
Net cash from financing activities(27)*35(226)*(332)*(47)*(195)(371)*(115)*(63)*(251)(129)*(222)*
Net change in cash121*60(188)*(51)*258*(14)(179)*116*368*(329)(49)*249*

Compare with peers

SIC 3826 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3826 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($M)Revenue, quarter ($M)Operating cash flow, quarter ($M)Shares outstandingQuarter
Illumina1,2891,129419*151.2M 10-QSep 27, 2026
Avantor4641,698195*677.6M 10-QSep 30, 2026
Revvity1,023730192*111.6M 10-QJul 5, 2026
Badger Meter6823643*28.6M 10-QSep 30, 2026
MKS4541,248243*67.6M 10-QJun 30, 2026
Teradyne4611,306314*156.1M 10-QSep 27, 2026
Itron840599102*43.9M 10-QSep 30, 2026
Vontier266757116*135.2M 10-QJul 3, 2026
Bio-Rad Laboratories51765199*not reported 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.